Why the study?
The study was conducted to examine the association between the use of multiple medications (polypharmacy) and mortality in community-dwelling elderly people.
Does polypharmacy increase mortality in community-dwelling elderly individuals?
Does polypharmacy increase mortality in community-dwelling elderly individuals?
Polypharmacy (excluding topical medications) is associated with higher mortality in community-dwelling elderly individuals, highlighting the need for careful medication management.
Highlights need for medication review in elderly outpatients; leaves open whether reducing polypharmacy lowers mortality.
In this study, we examined the association between the use of multiple medications (polypharmacy) and mortality in 116 community-dwelling elderly people. This retrospective cohort study included 116 participants randomly selected from a population of 1161 community-dwelling elderly individuals. Of the 116 participants, 60 (51.72 %) were female, with a mean age of 74.09±6.53 years at the start of the study in 2015. After a median follow-up of 2932 days, 37 participants (31.90 %) were identified as deceased. The results showed that higher mortality was associated with increased medication adherence and a higher total number of medications. Notably, the use of topical medications did not contribute to the observed mortality. When assessing polypharmacy, it is recommended to exclude topical medications from the count, as they were found to have no effect on mortality. These findings highlight the need for thoughtful medication management to improve health outcomes in older populations.
No takes yet. Share an insight, caveat, or question.
Kılınçarslan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: